Clearmind Medicine Inc. Operating Expense
Clearmind Medicine Inc. (CMND) reported Operating Expense of $3.66 million for the 3-month period ending 2026-01-31, per its 6-K filed 2026-03-12.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:OperatingExpense · last filed 2026-03-12
- Clearmind Medicine Inc. operating expense for the quarter ending 2023-01-31 was 2.47M CAD, a 18.59% increase year-over-year.
- Clearmind Medicine Inc. operating expense for the quarter ending 2022-01-31 was 2.08M CAD.
CAD
| Period end | Operating Expense 3 month | Operating Expense 12 month |
|---|---|---|
| 2023-01-31 | 2.47M CAD 6-K · filed 2023-03-17 | |
| 2022-10-31 | 8.53M CAD 20-F · filed 2023-02-06 | |
| 2022-01-31 | 2.08M CAD 6-K · filed 2023-03-17 | |
| 2021-10-31 | 3.68M CAD 20-F · filed 2023-02-06 | |
| 2020-10-31 | 233.22K CAD 20-F · filed 2023-02-06 |
USD
| Period end | Operating Expense 3 month | Operating Expense 6 month | Operating Expense 9 month | Operating Expense 12 month |
|---|---|---|---|---|
| 2026-01-31 | $3.66M 6-K · filed 2026-03-12 | $5.12M derived: sum of 2 quarters · filed 2026-03-12 | $6.52M derived: sum of 3 quarters · filed 2026-03-12 | $7.83M derived: sum of 4 quarters · filed 2026-03-12 |
| 2025-10-31 | $1.46M derived: 20-F 12 month − 6-K 9 month · filed 2026-01-20 | $2.86M derived: sum of 2 quarters · filed 2026-01-20 | $4.17M derived: sum of 3 quarters · filed 2026-01-20 | $5.67M 20-F · filed 2026-01-20 |
| 2025-07-31 | $1.41M 6-K · filed 2025-09-11 | $2.71M derived: sum of 2 quarters · filed 2025-09-11 | $4.21M 6-K · filed 2025-09-11 | $5.80M derived: sum of 4 quarters · filed 2026-03-12 |
| 2025-04-30 | $1.31M 6-K · filed 2025-06-12 | $2.80M 6-K · filed 2025-06-12 | $4.39M derived: sum of 3 quarters · filed 2026-03-12 | $5.86M derived: sum of 4 quarters · filed 2026-03-12 |
| 2025-01-31 | $1.50M 6-K · filed 2026-03-12 | $3.08M derived: sum of 2 quarters · filed 2026-03-12 | $4.55M derived: sum of 3 quarters · filed 2026-03-12 | $5.86M derived: sum of 4 quarters · filed 2026-03-12 |
| 2024-10-31 | $1.59M derived: 20-F 12 month − 6-K 9 month · filed 2026-01-20 | $3.06M derived: sum of 2 quarters · filed 2026-01-20 | $4.36M derived: sum of 3 quarters · filed 2026-01-20 | $5.74M 20-F · filed 2026-01-20 |
| 2024-07-31 | $1.47M 6-K · filed 2025-09-11 | $2.77M derived: sum of 2 quarters · filed 2025-09-11 | $4.16M 6-K · filed 2025-09-11 | $5.87M derived: sum of 4 quarters · filed 2026-01-20 |
| 2024-04-30 | $1.30M 6-K · filed 2025-06-12 | $2.69M 6-K · filed 2025-06-12 | $4.40M derived: sum of 3 quarters · filed 2026-01-20 | $5.50M derived: sum of 4 quarters · filed 2026-01-20 |
| 2024-01-31 | $1.38M 6-K · filed 2025-03-13 | $3.10M derived: sum of 2 quarters · filed 2026-01-20 | $4.20M derived: sum of 3 quarters · filed 2026-01-20 | $5.85M derived: sum of 4 quarters · filed 2026-01-20 |
| 2023-10-31 | $1.71M derived: 20-F 12 month − 6-K 9 month · filed 2026-01-20 | $2.81M derived: sum of 2 quarters · filed 2026-01-20 | $4.47M derived: sum of 3 quarters · filed 2026-01-20 | $6.30M 20-F · filed 2026-01-20 |
| 2023-07-31 | $1.10M 6-K · filed 2024-09-16 | $2.76M derived: sum of 2 quarters · filed 2024-09-16 | $4.59M 6-K · filed 2024-09-16 | |
| 2023-04-30 | $1.66M 6-K · filed 2024-06-13 | $3.49M 6-K · filed 2024-06-13 | ||
| 2023-01-31 | $1.83M 6-K · filed 2024-03-19 | |||
| 2022-10-31 | $6.25M 20-F · filed 2025-01-22 | |||
| 2022-04-30 | $2.22M 6-K · filed 2023-06-14 | $3.75M 6-K · filed 2023-06-14 | ||
| 2021-10-31 | $2.69M 20-F/A · filed 2024-03-18 |